These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 2121297
1. Amplified expression of three jun family members inhibits erythroleukemia differentiation. Prochownik EV, Smith MJ, Snyder K, Emeagwali D. Blood; 1990 Nov 01; 76(9):1830-7. PubMed ID: 2121297 [Abstract] [Full Text] [Related]
2. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation. Francastel C, Mazouzi Z, Robert-Lézénès J. Leukemia; 1992 Sep 01; 6(9):935-9. PubMed ID: 1518304 [Abstract] [Full Text] [Related]
3. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1. Ito E, Sweterlitsch LA, Tran PB, Rauscher FJ, Narayanan R. Oncogene; 1990 Dec 01; 5(12):1755-60. PubMed ID: 2178237 [Abstract] [Full Text] [Related]
4. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line. Francastel C, Groisman R, Pfarr CM, Robert-Lézénès J. Oncogene; 1994 Jul 01; 9(7):1957-64. PubMed ID: 8208542 [Abstract] [Full Text] [Related]
5. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Prochownik EV, Kukowska J. Nature; 1994 Jul 01; 322(6082):848-50. PubMed ID: 3528863 [Abstract] [Full Text] [Related]
6. NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity. Francastel C, Poindessous-Jazat V, Augery-Bourget Y, Robert-Lézénès J. Leukemia; 1997 Feb 01; 11(2):273-80. PubMed ID: 9009092 [Abstract] [Full Text] [Related]
7. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M, Boss GR, Pascual FE, Pilz RB. Cell Growth Differ; 1995 Dec 01; 6(12):1559-66. PubMed ID: 9019161 [Abstract] [Full Text] [Related]
8. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Liebermann DA, Hoffman B. Stem Cells; 1994 Jul 01; 12(4):352-69. PubMed ID: 7951003 [Abstract] [Full Text] [Related]
10. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Clarke MF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EV. Mol Cell Biol; 1988 Feb 01; 8(2):884-92. PubMed ID: 2832742 [Abstract] [Full Text] [Related]
11. C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells. Poindessous-Jazat V, Augery-Bourget Y, Robert-Lézénès J. Leukemia; 2002 Feb 01; 16(2):233-43. PubMed ID: 11840290 [Abstract] [Full Text] [Related]
12. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation. Kirsch IR, Bertness V, Silver J, Hollis GF. J Cell Biochem; 1986 Feb 01; 32(1):11-21. PubMed ID: 3464612 [Abstract] [Full Text] [Related]
13. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Ramsay RG, Ikeda K, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1986 Sep 01; 83(18):6849-53. PubMed ID: 3462732 [Abstract] [Full Text] [Related]
14. c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells. Francastel C, Augery-Bourget Y, Prenant M, Walters M, Martin DI, Robert-Lézénès J. Oncogene; 1997 Feb 20; 14(7):873-7. PubMed ID: 9047395 [Abstract] [Full Text] [Related]
15. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins. Lyon JJ, Watson RJ. Differentiation; 1995 Oct 20; 59(3):171-8. PubMed ID: 7589901 [Abstract] [Full Text] [Related]
16. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA. Mol Cell Biol; 1993 Feb 20; 13(2):841-51. PubMed ID: 8423806 [Abstract] [Full Text] [Related]
17. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Zhang L, Lemarchandel V, Romeo PH, Ben-David Y, Greer P, Bernstein A. Oncogene; 1993 Jun 20; 8(6):1621-30. PubMed ID: 8502483 [Abstract] [Full Text] [Related]
18. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation. Todokoro K, Ikawa Y. Biochem Biophys Res Commun; 1986 Mar 28; 135(3):1112-8. PubMed ID: 3457564 [Abstract] [Full Text] [Related]
19. Constitutive and inducible expression of megakaryocyte-specific genes in Friend erythroleukaemia cells. Vannucchi AM, Linari S, Cellai C, Koury MJ, Paoletti F. Br J Haematol; 1997 Dec 28; 99(3):500-8. PubMed ID: 9401056 [Abstract] [Full Text] [Related]
20. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO. Klinken SP, Holmes KL, Morse HC, Thorgeirsson SS. Exp Cell Res; 1988 Oct 28; 178(2):185-98. PubMed ID: 2458948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]